Catalytic Stereoconvergent Synthesis of Homochiral β-CF3, β-SCF3, and β-OCF3 Benzylic Alcohols
- PMID: 36217345
- PMCID: PMC9542724
- DOI: 10.1021/acsorginorgau.2c00019
Catalytic Stereoconvergent Synthesis of Homochiral β-CF3, β-SCF3, and β-OCF3 Benzylic Alcohols
Abstract
We describe an efficient catalytic strategy for enantio- and diastereoselective synthesis of homochiral β-CF3, β-SCF3, and β-OCF3 benzylic alcohols. The approach is based on dynamic kinetic resolution (DKR) with Noyori-Ikariya asymmetric transfer hydrogenation leading to simultaneous construction of two contiguous stereogenic centers with up to 99.9% ee, up to 99.9:0.1 dr, and up to 99% isolated yield. The origin of the stereoselectivity and racemization mechanism of DKR is rationalized by density functional theory calculations. Applicability of the previously inaccessible chiral fluorinated alcohols obtained by this method in two directions is further demonstrated: As building blocks for pharmaceuticals, illustrated by the synthesis of heat shock protein 90 inhibitor with in vitro anticancer activity, and in particular, needle-shaped crystals of representative stereopure products that exhibit either elastic or plastic flexibility, which opens the door to functional materials based on mechanically responsive chiral molecular crystals.
© 2022 The Authors. Published by American Chemical Society.
Conflict of interest statement
The authors declare no competing financial interest.
Figures
References
-
- Han J.; Remete A. M.; Dobson L. S.; Kiss L.; Izawa K.; Moriwaki H.; Soloshonok V. A.; O’Hagan D. Next Generation Organofluorine Containing Blockbuster Drugs.. J. Fluorine Chem. 2020, 239, 109639.10.1016/j.jfluchem.2020.109639. - DOI
-
- Mei H.; Remete A. M.; Zou Y.; Moriwaki H.; Fustero S.; Kiss L.; Soloshonok V. A.; Han J. Fluorine-Containing Drugs Approved by the FDA in 2019.. Chin. Chem. Lett. 2020, 31, 2401–2413. 10.1016/j.cclet.2020.03.050. - DOI
LinkOut - more resources
Full Text Sources
Research Materials